Apple, Inc AAPL
S&P 500 ETF Trust SPDR SPY
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Septerna, Inc. Common Stock, Common Stock

SEPN

NMQ

$25.9

-$1.19

(-4.39%)

Analyst Forecast

Overview Returns Financials Ratios News FAQs

Price Chart

Key Metrics

Market Cap info-icon

This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.

P/E Ratio

This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.

Volume

This is the total number of shares traded during the most recent trading day.

Avg Volume info-icon

This is the average number of shares traded during the most recent 30 days.

Dividend Yield info-icon

This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).

0.00%

Beta

This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

$18 L

$28.99 H

$25.9

About Septerna, Inc. Common Stock, Common Stock

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. The company develops SEP-786, an oral small molecule PTH1R agonist for hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 NAM for chronic spontaneous urticaria and other mast cell diseases; TSHR Program, an oral small molecule TSHR NAM for Graves' disease and thyroid eye disease. It also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders including obesity and type 2 diabetes. Septerna, Inc. was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. The company was incorporated in 2019 and is headquartered in South San Francisco, California. more

Returns

Data is not properly formatted.

Time Frame	SEPN		S&P500
1-Week Return	15.57%%	%	-1.49%%
1-Month Return	11.4%%	%	-0.37%%
3-Month Return	43.89%%	%	3.89%%

Financials

	Dec '22	Dec '23
Total Revenue	-	151.00K	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	27.97M	45.70M	[{"date":"2022-12-31","value":61.2,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	(27.97M)	(45.55M)	[{"date":"2022-12-31","value":-2796700000,"profit":false},{"date":"2023-12-31","value":-4555000000,"profit":false}]
Total Non-Operating Income/Expense	-	50.42M	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income	(27.68M)	4.87M	[{"date":"2022-12-31","value":-568.18,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	(27.68M)	4.18M	[{"date":"2022-12-31","value":-662.11,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	(27.68M)	4.18M	[{"date":"2022-12-31","value":-662.11,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]

EPS (Diluted)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

	Dec '22	Dec '23
Total Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Operating Expenses	-	63.41%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income	-	62.87%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income	-	(117.60%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Income From Continuous Operations	-	(115.10%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Income From Discontinued Operations	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income	-	(115.10%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

EPS (Diluted)	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]


Total Revenue	[]
Cost of Revenue	[]
Gross Profit	[]
Gross Margin	[]

Operating Expenses	[]
Operating Income	[]
Total Non-Operating Income/Expense	[]
Pre-Tax Income	[]
Income Taxes	[]
Income After Taxes	[]

Income From Continuous Operations	[]
Income From Discontinued Operations	[]
Net Income	[]

EPS (Diluted)	[]

	Dec '22	Dec '23
Total Assets
Current Assets	31.89M	112.68M	[{"date":"2022-12-31","value":28.3,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	4.23M	18.19M	[{"date":"2022-12-31","value":23.25,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	36.12M	130.87M	[{"date":"2022-12-31","value":27.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	5.54M	6.91M	[{"date":"2022-12-31","value":80.17,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	74.78M	162.33M	[{"date":"2022-12-31","value":46.07,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	80.32M	169.24M	[{"date":"2022-12-31","value":47.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	(50.76M)	(46.58M)	[{"date":"2022-12-31","value":-5075600000,"profit":false},{"date":"2023-12-31","value":-4657600000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	(44.20M)	(38.37M)	[{"date":"2022-12-31","value":-4420100000,"profit":false},{"date":"2023-12-31","value":-3837400000,"profit":false}]

Total Liabilities & Shareholders Equity	36.12M	130.87M	[{"date":"2022-12-31","value":27.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '22	Dec '23
Total Assets
Current Assets	-	253.33%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Assets	-	330.10%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Assets	-	262.32%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	24.73%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Non-current Liabilities	-	117.08%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Liabilities	-	110.71%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Retained Earnings	-	(8.24%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Total Shareholders' equity	-	(13.18%)	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":null,"profit":false}]

Total Liabilities & Shareholders Equity	-	262.32%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

	Dec '23	Jun '24
Total Assets
Current Assets	112.68M	151.22M	[{"date":"2023-12-31","value":74.51,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Assets	18.19M	25.41M	[{"date":"2023-12-31","value":71.58,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Assets	130.87M	176.63M	[{"date":"2023-12-31","value":74.09,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	6.91M	7.76M	[{"date":"2023-12-31","value":89.05,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Liabilities	162.33M	236.63M	[{"date":"2023-12-31","value":68.6,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Liabilities	169.24M	244.40M	[{"date":"2023-12-31","value":69.25,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Retained Earnings	(46.58M)	(77.18M)	[{"date":"2023-12-31","value":-4657600000,"profit":false},{"date":"2024-06-30","value":-7718300000,"profit":false}]
Other Stockholders' Equity	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Total Shareholders' equity	(38.37M)	(67.76M)	[{"date":"2023-12-31","value":-3837400000,"profit":false},{"date":"2024-06-30","value":-6776300000,"profit":false}]

Total Liabilities & Shareholders Equity	130.87M	176.63M	[{"date":"2023-12-31","value":74.09,"profit":true},{"date":"2024-06-30","value":100,"profit":true}]

	Dec '23	Jun '24
Total Assets
Current Assets	-	34.21%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Assets	-	39.70%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Assets	-	34.97%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Liabilities
Current Liabilities	-	12.29%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Non-current Liabilities	-	45.77%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Total Liabilities	-	44.41%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Shareholders' equity
Common Stock	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Retained Earnings	-	65.71%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]
Other Stockholders' Equity	-	-	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}]
Total Shareholders' equity	-	76.59%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]

Total Liabilities & Shareholders Equity	-	34.97%	[{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-06-30","value":100,"profit":true}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	(23.30M)	(38.72M)	[{"date":"2022-12-31","value":-2330300000,"profit":false},{"date":"2023-12-31","value":-3872300000,"profit":false}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	30.05M	74.52M	[{"date":"2022-12-31","value":40.33,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	5.46M	57.92M	[{"date":"2022-12-31","value":9.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	(24.59M)	(41.60M)	[{"date":"2022-12-31","value":-2459200000,"profit":false},{"date":"2023-12-31","value":-4160100000,"profit":false}]

	Dec '22	Dec '23
Operating Activities
Net Operating Cash Flow	-	66.17%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Investing Activities
Net Investing Cash Flow	-	-	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Financing Activities
Net Financing Cash Flow	-	147.98%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Net Change in Cash	-	960.98%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Free Cash Flow
Free Cash Flow	-	69.16%	[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

	SEPN
Current Ratio	19.48

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

	SEPN
ROA (LTM)	0.00%
ROE (LTM)	0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

	SEPN
Debt Ratio Lower is generally better. Negative is bad.	1.38
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier.	-0.38

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

	SEPN
Trailing PE	NM
Forward PE	NM
P/S (TTM)	0.00
P/B	0.00
EV/R	0.00
EV/Ebitda	NM

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

What is Septerna, Inc. Common Stock share price today?

Septerna, Inc. Common Stock (SEPN) share price today is $25.9

Can Indians buy Septerna, Inc. Common Stock shares?

Yes, Indians can buy shares of Septerna, Inc. Common Stock (SEPN) on Vested. To buy Septerna, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SEPN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Septerna, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Septerna, Inc. Common Stock (SEPN) via the Vested app. You can start investing in Septerna, Inc. Common Stock (SEPN) with a minimum investment of $1.

How to invest in Septerna, Inc. Common Stock shares from India?

You can invest in shares of Septerna, Inc. Common Stock (SEPN) via Vested in three simple steps:

Click on Sign Up or Invest in SEPN stock at the top of this page
Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
Transfer USD funds to your US Brokerage account and start investing in Septerna, Inc. Common Stock shares

What is Septerna, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Septerna, Inc. Common Stock (SEPN) is $28.99. The 52-week low price of Septerna, Inc. Common Stock (SEPN) is $18.

What is Septerna, Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Septerna, Inc. Common Stock (SEPN) is

What is Septerna, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Septerna, Inc. Common Stock (SEPN) is 0.00

What is Septerna, Inc. Common Stock dividend yield?

The dividend yield of Septerna, Inc. Common Stock (SEPN) is 0.00%

What is the Market Cap of Septerna, Inc. Common Stock?

The market capitalization of Septerna, Inc. Common Stock (SEPN) is

What is Septerna, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Septerna, Inc. Common Stock is SEPN

Feedback

Request to add more info/data

Inform about wrong info/data

Link copied

Signup to access all features and start your US investing journey!

Open your account in minutes
Take your portfolio global, starting at just $1

Get started

Add ticker to compare

Apple, Inc AAPL
Alphabet Inc. - Class A Shares GOOGL
Microsoft Corporation MSFT
Meta Platforms Inc META
Netflix, Inc. NFLX
Amazon.com Inc. AMZN
Spotify Technology SA SPOT

Global

India

Septerna, Inc. Common Stock, Common Stock

SEPN

NMQ

$25.9

-$1.19

(-4.39%)

Analyst Forecast

Price Chart

Key Metrics

52-week Range This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

About Septerna, Inc. Common Stock, Common Stock

Returns

Financials

Ratios

Liquidity

Asset Efficiency

Liabilities

Valuation

Discover more

Tesla, Inc.

Apple, Inc.

Alphabet Inc. - Class A Shares

Meta Platforms Inc

Amazon.com Inc.

Microsoft Corporation

NVIDIA Corporation

Berkshire Hathaway Inc. Hld B

Eli Lilly and Company

FAQs

Feedback

Request to add more info/data

Inform about wrong info/data

Signup to access all features and start your US investing journey!

Add ticker to compare

Popular US Stocks 1

Popular US ETFs 2

Curated Portfolios (Vests)

52-week Range
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).

Popular US Stocks ¹

Popular US ETFs ²